ISIN | CH0210193584 |
---|---|
Valor Number | 21019358 |
Bloomberg Global ID | UBS65QD SW |
Fund Name | UBS (CH) Suisse - 65 (CHF) Q-dist |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Global Advanced Markets Aggressive |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Well diversified portfolio with a focus on selected Swiss bonds, equities and real estate, complemented by a component of global bonds and equities|Equity weighting 65% |
Peculiarities |
Current Price * | 134.63 CHF | 12.05.2025 |
---|---|---|
Previous Price * | 133.49 CHF | 09.05.2025 |
52 Week High * | 137.78 CHF | 13.02.2025 |
52 Week Low * | 123.24 CHF | 09.04.2025 |
NAV * | 134.63 CHF | 12.05.2025 |
Issue Price * | 134.55 CHF | 12.05.2025 |
Redemption Price * | 134.55 CHF | 12.05.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 436,303,836 | |
Unit/Share Assets *** | 22,778,440 | |
Trading Information SIX |
YTD Performance | +3.24% |
31.12.2024 - 12.05.2025
31.12.2024 12.05.2025 |
---|---|---|
1 month | +6.03% |
14.04.2025 - 12.05.2025
14.04.2025 12.05.2025 |
3 months | -1.46% |
12.02.2025 - 12.05.2025
12.02.2025 12.05.2025 |
6 months | +3.43% |
12.11.2024 - 12.05.2025
12.11.2024 12.05.2025 |
1 year | +5.32% |
13.05.2024 - 12.05.2025
13.05.2024 12.05.2025 |
2 years | +11.27% |
12.05.2023 - 12.05.2025
12.05.2023 12.05.2025 |
3 years | +10.33% |
12.05.2022 - 12.05.2025
12.05.2022 12.05.2025 |
5 years | +25.77% |
12.05.2020 - 12.05.2025
12.05.2020 12.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UBS InvF Equities USA Index I-X-acc | 12.93% | |
---|---|---|
UBS CH IF3 RealEstSwitzFdsIdxNSL I-Xacc | 10.18% | |
UBS (CH) IF S&M Cap Equities Switz I-X | 8.89% | |
UBS (CH) IF Bds CHF Inl Corp Pasv II U-X | 7.37% | |
Nestle SA | 4.91% | |
UBS (CH) IF Bds CHF Aus Corp Pasv II U-X | 4.87% | |
UBS (CH) IF Bds CHF Prime Ausland U-X | 4.48% | |
Roche Holding AG | 4.28% | |
Novartis AG Registered Shares | 4.05% | |
UBS(Lux)FS MSCI EMU EUR Adis | 3.95% | |
Last data update | 31.03.2025 |
TER | 1.05% |
---|---|
TER date | 31.08.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.95% |
Ongoing Charges *** | 1.05% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |